Evidence map›Paper›PMID 41631773›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Intercellular Horizontal Transfer of TXNDC5 mRNA via Extracellular Vesicles Contributes to Tumor-Associated Macrophage-Mediated Prostate Cancer Metastasis.

Cong Hu, Tianyang Wu, Jiayi Wang, Xinxing Du, Xinrui Wu, Yanhao Dong, Zehong Peng, Penghui Liao, Zirui Guo, Zheyu Liu and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Integrative multi-omics reveals the POSTNFrontiers in immunology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Cong HuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0001-6503-7750
Tianyang WuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiayi WangDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xinxing DuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xinrui WuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yanhao DongDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zehong PengDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Penghui LiaoDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zirui GuoDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zheyu LiuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Kenneth J PientaThe Cancer Ecology Center, The Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Yinjie ZhuDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Jiahua PanDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Liang DongDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0001-7689-3237
Wei XueDepartment of Urology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Funding

Major Natural Science Research Projects of Shanghai Municipal Education Commission 2023ZKZD23National Natural Science Foundation of China 82103485National Natural Science Foundation of China 82227801National Natural Science Foundation of China 82373358National Natural Science Foundation of China 82472142Physician-Scientist Development Award from Shanghai Immune Therapy InstituteShanghai High-level Local Universities Construction ProgramShanghai Jiao Tong UniversityShanghai Jiao Tong University School of Medicine Institute of Molecular Medicine Clinical+ Excellence Program 2025ZYA-001Shanghai Municipal Health Commission Outstanding Young Talents Program 2022YQ014Shanghai Professional Technical Service Platform 23DZ2291000Shanghai Rising-Star Program 23QA1405900Shanghai Top Priority Research Center Project 2023ZZ02014
6 · The paper itself

Abstract

As one of the predominant male malignancies globally, prostate cancer (PCa) transitions to a treatment-refractory phase upon metastasis, for which no curative modalities currently exist. Tumor-associated macrophages (TAMs), a crucial component of the tumor microenvironment (TME), primarily adopt a metastasis-promoting M2 phenotype. However, the mechanisms underlying the TAM-cancer cell crosstalk and resultant PCa metastasis remain elusive. In this study, primary lesions of metastatic PCa (mPCa) exhibit both greater infiltration of M2 macrophages and a higher proportion of M2 macrophage-derived extracellular vesicles (M2 EVs) compared to those of non-metastatic PCa (nmPCa). Furthermore, M2 EVs can be internalized by PCa cells, promoting a mesenchymal-like state (MLS) in PCa and affecting tumor metastasis. Mechanistically, thioredoxin domain-containing 5 (TXNDC5) mRNA encapsulated in M2 EVs contributes to MLS of DU145 and PC3 cells, enhancing migration and invasion. Single-vesicle particle analysis confirms that TXNDC5 mRNA encapsulated within M2 EVs can be horizontally transferred to target cells, where it is translated to produce functional proteins. In conclusion, our study demonstrates that M2 macrophages can promote MLS and metastasis of PCa through EV-mediated horizontal mRNA transfer. A novel role of EVs in the communication between the TME and tumor cells is discovered, offering new insights into tumor metastasis.

Indexed as

Extracellular VesiclesProstatic NeoplasmsRNA, MessengerTumor-Associated MacrophagesAnimalsCell Line, TumorCell MovementHumansMaleMiceNeoplasm MetastasisTumor MicroenvironmentRNA, Messengerextracellular vesiclesmesenchymal‐like statemetastasisprostate cancertumor‐associated macrophages

Identifiers

PMID41631773
PMCPMC12955867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.